Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Neuromedin S

Introduction

Neuromedin S is a 36-amino acid neuropeptide found in the brain of humans and other mammals. It is produced in the suprachiasmatic nucleus of the hypothalamus and is related to neuromedin U. It is thought to be involved in regulation of circadian rhythm and also has appetite suppressant effects,[1][2][3][4][5] as well as regulating the release of several other peptide hormones including vasopressin,[6] luteinizing hormone,[7] and oxytocin.[8]

See also

See also

References

References

  1. ↑ Mori K, Miyazato M, Ida T, Murakami N, Serino R, Ueta Y, Kojima M, Kangawa K (January 2005). “Identification of neuromedin S and its possible role in the mammalian circadian oscillator system”. The EMBO Journal. 24 (2): 325–35. doi:10.1038/sj.emboj.7600526. PMC 545815. PMID 15635449.
  2. ↑ Mori K, Miyazato M, Kangawa K (2008). “Neuromedin S: discovery and functions”. Results and Problems in Cell Differentiation. 46: 201–12. doi:10.1007/400_2007_054. PMID 18214396.
  3. ↑ Novak CM (July 2009). “Neuromedin S and U”. Endocrinology. 150 (7): 2985–7. doi:10.1210/en.2009-0448. PMC 2703548. PMID 19549882.
  4. ↑ Peier A, Kosinski J, Cox-York K, Qian Y, Desai K, Feng Y, Trivedi P, Hastings N, Marsh DJ (July 2009). “The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2)”. Endocrinology. 150 (7): 3101–9. doi:10.1210/en.2008-1772. PMC 2703546. PMID 19324999.
  5. ↑ Mitchell J, Maguire J, Davenport A (June 2009). “Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S”. British Journal of Pharmacology. 158 (1): 87–103. doi:10.1111/j.1476-5381.2009.00252.x. PMC 2795236. PMID 19519756.
  6. ↑ Sakamoto T, Mori K, Nakahara K, Miyazato M, Kangawa K, Sameshima H, Murakami N (September 2007). “Neuromedin S exerts an antidiuretic action in rats”. Biochemical and Biophysical Research Communications. 361 (2): 457–61. doi:10.1016/j.bbrc.2007.07.036. PMID 17645872.
  7. ↑ Vigo E, Roa J, López M, Castellano JM, Fernandez-Fernandez R, Navarro VM, Pineda R, Aguilar E, Diéguez C, Pinilla L, Tena-Sempere M (February 2007). “Neuromedin s as novel putative regulator of luteinizing hormone secretion”. Endocrinology. 148 (2): 813–23. doi:10.1210/en.2006-0636. PMID 17110433.
  8. ↑ Sakamoto T, Mori K, Miyazato M, Kangawa K, Sameshima H, Nakahara K, Murakami N (October 2008). “Involvement of neuromedin S in the oxytocin release response to suckling stimulus”. Biochemical and Biophysical Research Communications. 375 (1): 49–53. doi:10.1016/j.bbrc.2008.07.124. PMID 18675786.